Patient Enrollment Advisors

Patient Enrollment Advisors (PEA) is a specialized clinical trial service provider focused on optimizing patient recruitment and enrollment processes for the life sciences industry. The company provides strategic consulting, site-level support, and data-driven recruitment solutions to help pharmaceutical companies and CROs meet enrollment timelines. PEA's approach emphasizes reducing the burden on clinical sites while improving the efficiency of identifying and consenting eligible participants. In 2018, the company was acquired by WCG (WIRB-Copernicus Group) to enhance its suite of clinical trial optimization services. Today, its capabilities are integrated into WCG’s broader clinical trial solutions, supporting global trials across various therapeutic areas.